Drug Shortage Report for BREVICON 0.5/35 TABLETS (28-DAY PACK)
| Report ID | 119176 |
| Drug Identification Number | 02187094 |
| Brand name | BREVICON 0.5/35 TABLETS (28-DAY PACK) |
| Common or Proper name | BREVICON 28 |
| Company Name | PFIZER CANADA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | ETHINYL ESTRADIOL NORETHINDRONE |
| Strength(s) | .035MG .5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 28's |
| ATC code | G03AA |
| ATC description | HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-06-29 |
| Estimated end date | 2021-02-22 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2021-01-15 |
| Company comments | Recovery expected during Feb 2021. |
| Health Canada comments | |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.